跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PERINDOPRIL ERBUMINE/ INDAPAMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PERINDOPRIL ERBUMINE/ INDAPAMIDE
Authorized
STANDARD
PERINDOPRIL ERBUMINE/ INDAPAMIDE
sivem pharmaceuticals ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
60e8468b4c94594c
Company
sivem pharmaceuticals ulc
Type
Standard
Approval Details
Approval Id
60e8468b4c94594c
Drug Approval Canada Name
PERINDOPRIL ERBUMINE/ INDAPAMIDE
Product Name
PERINDOPRIL ERBUMINE/ INDAPAMIDE
Status
Marketed
Status Date
2022-01-20
Original Market Date
2022-01-20
Din
02479834
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:28.24
Atc Original
C09BA04 PERINDOPRIL AND DIURETICS
Atc Name
c 09 ba 04
Aig Number
0248401001
Company Name
sivem pharmaceuticals ulc
Company Address
4705 Dobrin Street, Saint-Laurent, Quebec, Canada, H4R 2P7
Active Ingredients
INDAPAMIDE
1.25 MG
PERINDOPRIL ERBUMINE
4 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
60e8468b4c94594c
Type
Standard
Back to Health Canada Approvals